The University of Sheffield announces approval of the first human trial testing regenerative cell therapy to treat sensorineural hearing loss, offering hope for restoring hearing function.
Data reveals that patients with heart disease who come from disadvantaged communities experience more complications after their surgery – including a higher risk of death.
Though the UK’s recommended alcohol limit is under 14 units weekly, researchers still suggest less, as the risk of cardiovascular diseases can still be increased by even moderate amounts.
The human immune system is an intricate web designed to stop invading pathogens - but with over 200 virus species capable of infecting humans, some have a way to break through.
Research has found that low-intensity transcranial ultrasound stimulation can modulate brain activity and behaviours, supporting the observations of psychiatric conditions.
Wearable devices are being used as part of a cardiology programme “Our Hearts Our Minds” to support patients at risk of, or who have a cardiovascular condition.
Alzheimer’s disease, a growing silent pandemic, is discussed here by Project Alzheimer’s Value Europe (PAVE), who introduce their stakeholder forum that focuses on developing new research in the field, such as emerging therapeutic & diagnostic innovations.
Shiao Fong Yee, Marketing Communications Manager at Novacyt Group, discusses the importance of rapid testing to differentiate between COVID-19 and other infections in light of facing winter respiratory viral challenges.
